Individualizing long-term treatment and care in active MS
touchIN CONVERSATION for touchNEUROLOGY
Listen to Dr Ruth Dobson (Queen Mary University of London, UK) in conversation with Dr Ide Smets (MS Center ErasMS, Rotterdam, The Netherlands). They discuss questions submitted by the healthcare professional (HCP) audience and provide their expert insights on the practicalities of therapeutic sequencing options in multiple sclerosis (MS).
Clinical themes:
Factors guiding the use of high-efficacy disease-modifying therapies (DMTs) in the management of active MS (02:01)
Current approaches and safety considerations relating to DMT switching and sequencing…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.